;PMID: 9224697
;source_file_1942.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:44..124] = [t:44..124]
;2)section:[e:128..197] = [t:128..197]
;3)section:[e:201..350] = [t:201..350]
;4)sentence:[e:354..544] = [t:354..544]
;5)sentence:[e:545..723] = [t:545..723]
;6)sentence:[e:724..859] = [t:724..859]
;7)sentence:[e:860..986] = [t:860..986]
;8)sentence:[e:987..1115] = [t:987..1115]
;9)sentence:[e:1116..1241] = [t:1116..1241]
;10)sentence:[e:1242..1340] = [t:1242..1340]
;11)section:[e:1344..1388] = [t:1344..1388]

;section 0 Span:0..38
;FEBS Lett. 1997 Jun 16;409(3):396-400.
(SEC
  (FRAG (NNP:[0..4] FEBS) (NNP:[5..9] Lett) (.:[9..10] .) (CD:[11..15] 1997)
        (NNP:[16..19] Jun) (CC:[20..26] 16;409) (-LRB-:[26..27] -LRB-)
        (CD:[27..28] 3) (-RRB-:[28..29] -RRB-) (::[29..30] :)
        (CD:[30..37] 396-400) (.:[37..38] .)))

;sentence 1 Span:44..124
;A novel activity for a group of sesquiterpene lactones: inhibition of
;aromatase.
;[76..98]:substance:"sesquiterpene lactones"
;[114..123]:cyp450:"aromatase"
(SENT
  (NP-HLN
    (NP
      (NP (DT:[44..45] A) (JJ:[46..51] novel) (NN:[52..60] activity))
      (PP (IN:[61..64] for)
        (NP
          (NP (DT:[65..66] a) (NN:[67..72] group))
          (PP (IN:[73..75] of)
            (NP (NN:[76..89] sesquiterpene) (NNS:[90..98] lactones))))))
    (::[98..99] :)
    (NP
      (NP (NN:[100..110] inhibition))
      (PP (IN:[111..113] of)
        (NP (NN:[114..123] aromatase))))
    (.:[123..124] .)))

;section 2 Span:128..197
;Blanco JG, Gil RR, Alvarez CI, Patrito LC, Genti-Raimondi S, Flury A.
(SEC
  (FRAG (NNP:[128..134] Blanco) (NNP:[135..137] JG) (,:[137..138] ,)
        (NNP:[139..142] Gil) (NNP:[143..145] RR) (,:[145..146] ,)
        (NNP:[147..154] Alvarez) (NNP:[155..157] CI) (,:[157..158] ,)
        (NNP:[159..166] Patrito) (NNP:[167..169] LC) (,:[169..170] ,)
        (NNP:[171..185] Genti-Raimondi) (NNP:[186..187] S) (,:[187..188] ,)
        (NNP:[189..194] Flury) (NNP:[195..196] A) (.:[196..197] .)))

;section 3 Span:201..350
;Departamento de Bioquimica Clinica-IMBIV (CONICET), Facultad de Ciencias 
;Quimicas, Universidad Nacional de Cordoba, Argentina. jblanco@fcq.uncor.edu
(SEC
  (FRAG (NNP:[201..213] Departamento) (IN:[214..216] de)
        (NNP:[217..227] Bioquimica) (NNP:[228..241] Clinica-IMBIV)
        (-LRB-:[242..243] -LRB-) (NN:[243..250] CONICET)
        (-RRB-:[250..251] -RRB-) (,:[251..252] ,) (NNP:[253..261] Facultad)
        (IN:[262..264] de) (NNP:[265..273] Ciencias) (NNP:[275..283] Quimicas)
        (,:[283..284] ,) (NNP:[285..296] Universidad) (NNP:[297..305] Nacional)
        (IN:[306..308] de) (NNP:[309..316] Cordoba) (,:[316..317] ,)
        (NNP:[318..327] Argentina) (.:[327..328] .)
        (IN:[329..346] jblanco@fcq.uncor) (NN:[346..350] .edu)))

;sentence 4 Span:354..544
;A group of eleven sesquiterpene lactones isolated from different Asteraceae 
;species from north-western Argentina were investigated for their inhibitory 
;action on the estrogen biosynthesis.
;[372..394]:substance:"sesquiterpene lactones"
;[522..530]:substance:"estrogen"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[354..355] A) (NN:[356..361] group))
      (PP (IN:[362..364] of)
        (NP
          (NP (CD:[365..371] eleven)
             (NN:[372..385] sesquiterpene) (NNS:[386..394] lactones))
          (VP (VBN:[395..403] isolated)
            (NP (-NONE-:[403..403] *))
            (PP (IN:[404..408] from)
              (NP
                (NP (JJ:[409..418] different) (NNS:[419..429] Asteraceae)
                    (NNS:[431..438] species))
                (PP (IN:[439..443] from)
                  (NP
                    (ADJP (JJ:[444..449] north) (HYPH:[449..450] -)
                          (JJ:[450..457] western))
                    (NNP:[458..467] Argentina)))))))))
    (VP (VBD:[468..472] were)
      (VP (VBN:[473..485] investigated)
        (NP-1 (-NONE-:[485..485] *))
        (PP (IN:[486..489] for)
          (NP
            (NP (PRP$:[490..495] their) (JJ:[496..506] inhibitory)
                (NN:[508..514] action))
            (PP (IN:[515..517] on)
              (NP (DT:[518..521] the) (NN:[522..530] estrogen)
                  (NN:[531..543] biosynthesis)))))))
    (.:[543..544] .)))

;sentence 5 Span:545..723
;Seven of them, of different skeleton types,  were found to inhibit the
;aromatase enzyme activity in human placental  microsomes, showing IC50 values
;ranging from 7 to 110 microM.
;[616..632]:cyp450:"aromatase enzyme"
;[682..686]:quantitative-name:"IC50"
;[707..715]:quantitative-value:"7 to 110"
;[716..722]:quantitative-units:"microM"
(SENT
  (S
    (NP-SBJ-2
      (NP (CD:[545..550] Seven))
      (PP (IN:[551..553] of)
        (NP (PRP:[554..558] them)))
      (,:[558..559] ,)
      (PP (IN:[560..562] of)
        (NP (JJ:[563..572] different) (NN:[573..581] skeleton)
            (NNS:[582..587] types))))
    (,:[587..588] ,)
    (VP (VBD:[590..594] were)
      (VP (VBN:[595..600] found)
        (S
          (NP-SBJ-2 (-NONE-:[600..600] *))
          (VP (TO:[601..603] to)
            (VP (VB:[604..611] inhibit)
              (NP (DT:[612..615] the)
                 (NN:[616..625] aromatase) (NN:[626..632] enzyme)
                (NN:[633..641] activity))
              (PP-LOC (IN:[642..644] in)
                (NP (JJ:[645..650] human) (JJ:[651..660] placental)
                    (NNS:[662..672] microsomes)))
              (,:[672..673] ,)
              (S-ADV
                (NP-SBJ (-NONE-:[673..673] *))
                (VP (VBG:[674..681] showing)
                  (NP
                    (NP (NN:[682..686] IC50) (NNS:[687..693] values))
                    (VP (VBG:[694..701] ranging)
                      (PP (IN:[702..706] from)
                        (NP (CD:[707..708] 7)
                          (NML-1 (-NONE-:[708..708] *RNR*))))
                      (PP (TO:[709..711] to)
                        (NP (CD:[712..715] 110)
                          (NML-1 (-NONE-:[715..715] *RNR*))))
                      (NML-1 (NN:[716..722] microM)))))))))))
    (.:[722..723] .)))

;sentence 6 Span:724..859
;The most active  were the guaianolides 10-epi-8-deoxycumambrin B (compound
;1), dehydroleucodin  (compound 2) and ludartin (compound 3).
;[750..762]:substance:"guaianolides"
;[763..788]:substance:"10-epi-8-deoxycumambrin B"
;[790..800]:substance:"compound 1"
;[803..818]:substance:"dehydroleucodin"
;[821..831]:substance:"compound 2"
;[837..845]:substance:"ludartin"
;[847..857]:substance:"compound 3"
(SENT
  (S
    (NP-SBJ (DT:[724..727] The)
      (ADJP (RBS:[728..732] most) (JJ:[733..739] active)))
    (VP (VBD:[741..745] were)
      (NP-PRD
        (NP (DT:[746..749] the) (NNS:[750..762] guaianolides))
        (NP
          (NP
            (NP (NN:[763..786] 10-epi-8-deoxycumambrin) (NN:[787..788] B))
            (NP (-LRB-:[789..790] -LRB-)
               (NN:[790..798] compound) (CD:[799..800] 1)
              (-RRB-:[800..801] -RRB-)))
          (,:[801..802] ,)
          (NP
            (NP (NN:[803..818] dehydroleucodin))
            (NP (-LRB-:[820..821] -LRB-)
               (NN:[821..829] compound) (CD:[830..831] 2)
              (-RRB-:[831..832] -RRB-)))
          (CC:[833..836] and)
          (NP
            (NP (NN:[837..845] ludartin))
            (NP (-LRB-:[846..847] -LRB-)
               (NN:[847..855] compound) (CD:[856..857] 3)
              (-RRB-:[857..858] -RRB-))))))
    (.:[858..859] .)))

;sentence 7 Span:860..986
;These compounds were competitive  inhibitors with an apparent Ki = 4 microM,
;Ki = 21 microM and Ki = 23 microM,  respectively.
;[866..875]:substance:"compounds"
;[894..904]:substance:"inhibitors"
;[922..924]:quantitative-name:"Ki"
;[927..928]:quantitative-value:"4"
;[929..935]:quantitative-units:"microM"
;[937..939]:quantitative-name:"Ki"
;[942..944]:quantitative-value:"21"
;[945..951]:quantitative-units:"microM"
;[956..958]:quantitative-name:"Ki"
;[961..963]:quantitative-value:"23"
;[964..970]:quantitative-units:"microM"
(SENT
  (S
    (NP-SBJ (DT:[860..865] These) (NNS:[866..875] compounds))
    (VP (VBD:[876..880] were)
      (NP (JJ:[881..892] competitive) (NNS:[894..904] inhibitors))
      (PP (IN:[905..909] with)
        (NP
          (NP (DT:[910..912] an)
            (NML
              (NML
                (NML
                  (ADJP-1 (JJ:[913..921] apparent))
                  (NN:[922..924] Ki))
                (ADJP (SYM:[925..926] =)
                  (NP (CD:[927..928] 4) (NN:[929..935] microM))))
              (,:[935..936] ,)
              (NML
                (NML
                  (ADJP-1 (-NONE-:[936..936] *P*))
                  (NN:[937..939] Ki))
                (ADJP (SYM:[940..941] =)
                  (NP (CD:[942..944] 21) (NN:[945..951] microM))))
              (CC:[952..955] and)
              (NML
                (NML
                  (ADJP-1 (-NONE-:[955..955] *P*))
                  (NN:[956..958] Ki))
                (ADJP (SYM:[959..960] =)
                  (NP (CD:[961..963] 23) (NN:[964..970] microM))))))
          (,:[970..971] ,)
          (ADVP (RB:[973..985] respectively)))))
    (.:[985..986] .)))

;sentence 8 Span:987..1115
;Compounds 1 and 2 acted as type II ligands to the heme iron  present in the
;active site of aromatase cytochrome P450 (P450arom).
;[987..998]:substance:"Compounds 1"
;[987..996]...[1003..1004]:substance:"Compounds"..."2"
;[1014..1029]:substance:"type II ligands"
;[1078..1103]:cyp450:"aromatase cytochrome P450"
;[1105..1113]:cyp450:"P450arom"
(SENT
  (S
    (NP-SBJ
      (NP
        (NML-1 (NNS:[987..996] Compounds))
        (CD:[997..998] 1))
      (CC:[999..1002] and)
      (NP
        (NML-1 (-NONE-:[1002..1002] *P*))
        (CD:[1003..1004] 2)))
    (VP (VBD:[1005..1010] acted)
      (PP (IN:[1011..1013] as)
        (NP
          (NP
            (NML (NN:[1014..1018] type) (CD:[1019..1021] II))
            (NNS:[1022..1029] ligands))
          (PP (TO:[1030..1032] to)
            (NP
              (NP (DT:[1033..1036] the) (NN:[1037..1041] heme)
                  (NN:[1042..1046] iron))
              (ADJP (JJ:[1048..1055] present)
                (PP-LOC (IN:[1056..1058] in)
                  (NP
                    (NP (DT:[1059..1062] the) (JJ:[1063..1069] active)
                        (NN:[1070..1074] site))
                    (PP (IN:[1075..1077] of)
                      (NP
                        (NP (NN:[1078..1087] aromatase)
                            (NN:[1088..1098] cytochrome) (NN:[1099..1103] P450))
                        (NP (-LRB-:[1104..1105] -LRB-)
                            (NN:[1105..1113] P450arom)
                            (-RRB-:[1113..1114] -RRB-))))))))))))
    (.:[1114..1115] .)))

;sentence 9 Span:1116..1241
;Besides, all  of them failed to affect the cholesterol side-chain cleavage
;enzyme activity on  human placental mitochondrias.
;[1159..1197]:cyp450:"cholesterol side-chain cleavage enzyme"
(SENT
  (S
    (ADVP (IN:[1116..1123] Besides))
    (,:[1123..1124] ,)
    (NP-SBJ-1
      (NP (DT:[1125..1128] all))
      (PP (IN:[1130..1132] of)
        (NP (PRP:[1133..1137] them))))
    (VP (VBD:[1138..1144] failed)
      (S
        (NP-SBJ-1 (-NONE-:[1144..1144] *))
        (VP (TO:[1145..1147] to)
          (VP (VB:[1148..1154] affect)
            (NP (DT:[1155..1158] the)
              
              (NML (NN:[1159..1170] cholesterol)
                (NML (NN:[1171..1175] side) (HYPH:[1175..1176] -)
                     (NN:[1176..1181] chain))
                (NN:[1182..1190] cleavage))
              (NN:[1191..1197] enzyme)
              (NN:[1198..1206] activity)))))
      (PP (IN:[1207..1209] on)
        (NP (JJ:[1211..1216] human) (JJ:[1217..1226] placental)
            (NNS:[1227..1240] mitochondrias))))
    (.:[1240..1241] .)))

;sentence 10 Span:1242..1340
;This is the first report on the aromatase  inhibitory activity of this group
;of natural compounds.
;[1274..1283]:cyp450:"aromatase"
(SENT
  (S
    (NP-SBJ (DT:[1242..1246] This))
    (VP (VBZ:[1247..1249] is)
      (NP-PRD
        (NP (DT:[1250..1253] the) (JJ:[1254..1259] first)
            (NN:[1260..1266] report))
        (PP (IN:[1267..1269] on)
          (NP
            (NP (DT:[1270..1273] the) (NN:[1274..1283] aromatase)
                (JJ:[1285..1295] inhibitory) (NN:[1296..1304] activity))
            (PP (IN:[1305..1307] of)
              (NP
                (NP (DT:[1308..1312] this) (NN:[1313..1318] group))
                (PP (IN:[1319..1321] of)
                  (NP (JJ:[1322..1329] natural) (NNS:[1330..1339] compounds)))))))))
    (.:[1339..1340] .)))

;section 11 Span:1344..1388
;PMID: 9224697 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1344..1348] PMID) (::[1348..1349] :) (CD:[1350..1357] 9224697)
        (NN:[1358..1359] -LSB-) (NNP:[1359..1365] PubMed) (::[1366..1367] -)
        (NN:[1368..1375] indexed) (IN:[1376..1379] for)
        (NNP:[1380..1388] MEDLINE-RSB-)))
